The impact of these changes for those above mentioned periods are below:

Quarterly Condensed Consolidated Balance Sheet	2017						Restatement Adjustments as of March 31, 2017														2017
	Balance as of March 31 as reported			Effect of restatement January 1			Sales & Use Tax			Warrants			Debentures			Intangible Impairment		Deferred Revenue			Balance as of March 31 as restated
Assets
Current assets:
Cash and cash equivalents	$	3,763		$	-		$	-		$	-		$	-		$	-	$	-		$	3,763
Accounts receivable, net		3,288																				3,288
Inventories		2,670																				2,670
Prepaid expenses and other current assets		804																				804
Total current assets		10,525																				10,525


Property and equipment, net		9,975																				9,975
Intangible assets, net		13,858																				13,858
Goodwill		8,803																				8,803
Other assets		46																				46
Total assets	$	43,207		$	-		$	-		$	-		$	-		$	-	$	-		$	43,207


Liabilities and stockholders’ equity
Current liabilities:
Note payable	$	239		$	-		$	-		$	-		$	-		$	-	$	-		$	239
Current portion of long-term debt		2,571																				2,571
Accounts payable		2,206																				2,206
Other accrued liabilities		2,214			917			135														3,266
Deferred revenues		334			1,995														(197	)		2,132
Total current liabilities		7,564			2,912			135			-			-			-		(197	)		10,414

Long-term debt, net		8,948																				8,948
Senior secured convertible debentures, net		12,695			(6,945	)								(476	)							5,274
Derivative liability senior secured convertible debentures		-			3,158									1,738								4,896
Deferred tax liability		419																				419
Warrant liability		237			557						539											1,333
Other liabilities		752																				752

Total liabilities		30,615			(318	)		135			539			1,262			-		(197	)		32,036

Stockholders’ equity:
Preferred stock Convertible Preferred Stock		1																				1
Common stock		2																				2
Additional paid-in capital		225,397			(27,814	)																197,583
Accumulated deficit		(212,810	)		28,132			(135	)		(539	)		(1,262	)				197			(186,417	)
Accumulated other comprehensive income		2																				2
Total stockholders’ equity		12,592			318			(135	)		(539	)		(1,262	)		-		197			11,171

Total liabilities and stockholders’ equity	$	43,207		$	-		$	-		$	-		$	-		$	-	$	-		$	43,207

Quarterly Condensed Consolidated Statement of Operations	2017			Restatement Adjustments for the Three Months Ended March 31, 2017																2017
	Three months ended March 31 as reported			Sales & Use Tax			Warrants			Debentures			Intangible Impairment		Deferred Revenue		Other Adjustments			Three months ended March 31 as restated
Revenues, net	$	7,097		$	-		$	-		$	-		$	-	$	197	$	(25	)	$	7,269

Cost of revenues		2,733																			2,733

Gross profit		4,364			-			-			-			-		197		(25	)		4,536

Operating expenses:
Engineering and product development		475																			475
Selling and marketing		2,975																			2,975
General and administrative		1,601			135													(25	)		1,711
		5,051			135			-			-			-		-		(25	)		5,161

Loss from operations		(687	)		(135	)		-			-			-		197		-			(625	)

Other expense, net:
Interest expense, net		(1,346	)								476										(870	)
Change in fair value of warrant liability		(132	)					(539	)												(671	)
Change in fair value of embedded conversion feature		-									(1,738	)									(1,738	)
Loss on extinguishment of debentures		-																			-
Other expense, net		-						-													-
		(1,478	)		-			(539	)		(1,262	)		-		-		-			(3,279	)

Loss before income taxes		(2,165	)		(135	)		(539	)		(1,262	)		-		197		-			(3,904	)
Income tax expense		(70	)																		(70	)
Net loss	$	(2,235	)	$	(135	)	$	(539	)	$	(1,262	)	$	-	$	197	$	-		$	(3,974	)
Loss attributable to common shares	$	(2,235	)																	$	(3,974	)

Loss per common share
Basic	$	(1.03	)																	$	(1.83	)
Diluted	$	(1.03	)																	$	(1.83	)
Shares used in computing loss per common share
Basic		2,176,731																			2,176,731
Diluted		2,176,731																			2,176,731

Quarterly Condensed Consolidated Balance Sheet	2017						Restatement Adjustments as of June 30, 2017														2017
	Balance as of June 30 as reported			Effect of restatement April 1			Sales & Use Tax			Warrants			Debentures			Intangible Impairment		Deferred Revenue			Balance as of June 30 as restated
Assets
Current assets:
Cash and cash equivalents	$	3,938		$	-		$	-		$	-		$	-		$	-	$	-		$	3,938
Accounts receivable, net		3,560																				3,560
Inventories		3,487																				3,487
Prepaid expenses and other current assets		373																				373
Total current assets		11,358															-					11,358


Property and equipment, net		9,396																				9,396
Intangible assets, net		13,298																				13,298
Goodwill		8,803																				8,803
Other assets		47																				47
Total assets	$	42,902		$	-		$	-		$	-		$	-		$	-	$	-		$	42,902


Liabilities and stockholders’ equity
Current liabilities:
Note payable	$	137		$	-		$	-		$	-		$	-		$	-	$	-		$	137
Current portion of long-term debt		3,429																				3,429
Accounts payable		2,301																				2,301
Other accrued liabilities		2,160			1,052			147														3,359
Deferred revenues		413			1,798														(1	)		2,210
Total current liabilities		8,440			2,850			147			-			-			-		(1	)		11,436

Long-term debt, net		8,150			-																	8,150
Senior secured convertible debentures, net		13,386			(7,421	)								(378	)							5,587
Derivative liability senior secured convertible debentures		-			4,896									(2,903	)							1,993
Deferred tax liability		479			-																	479
Warrant liability		109			1,096						(529	)										676
Other liabilities		724																				724

Total liabilities		31,288			1,421			147			(529	)		(3,281	)		-		(1	)		29,045

Stockholders’ equity:
Preferred stock Convertible Preferred Stock		-																				-
Common stock		3																				3
Additional paid-in capital		225,624			(27,814	)																197,810
Accumulated deficit		(214,015	)		26,393			(147	)		529			3,281					1			(183,958	)
Accumulated other comprehensive income		2																				2
Total stockholders’ equity		11,614			(1,421	)		(147	)		529			3,281			-		1			13,857

Total liabilities and stockholders’ equity	$	42,902		$	-		$	-		$	-		$	-		$	-	$	-		$	42,902

Quarterly Condensed Consolidated Statement of Operations	2017			Restatement Adjustments for the Three Months Ended June 30, 2017														2017
	Three months ended June 30 as reported			Sales & Use Tax			Warrants		Debentures		Intangible Impairment		Deferred Revenue		Other Adjustments			Three months ended June 30 as restated
Revenues, net	$	8,471		$	-		$	-	$	-	$	-	$	1	$	(27	)	$	8,445

Cost of revenues		3,173																	3,173

Gross profit		5,298			-			-		-		-		1		(27	)		5,272

Operating expenses:
Engineering and product development		423																	423
Selling and marketing		2,846																	2,846
General and administrative		1,720			147									-		(27	)		1,840
		4,989			147			-		-		-		-		(27	)		5,109

Income (loss) from operations		309			(147	)		-		-		-		1		-			163

Other income (expense), net:
Interest expense, net		(1,575	)							378									(1,197	)
Change in fair value of warrant liability		128						529											657
Change in fair value of embedded conversion feature										2,903									2,903
Income (loss) on extinguishment of debentures		-																	-
Other income, net		6						-											6
		(1,441	)		-			529		3,281		-		-		-			2,369

Income (loss) before income taxes		(1,132	)		(147	)		529		3,281		-		1		-			2,532
Income tax expense		(73	)																(73	)
Net income (loss)	$	(1,205	)	$	(147	)	$	529	$	3,281	$	-	$	1	$	-		$	2,459
Income (loss) attributable to common shares	$	(1,205	)															$	2,459

Earnings (loss) per common share
Basic	$	(0.52	)															$	0.90
Diluted	$	(0.52	)															$	(0.01	)
Shares used in computing earnings (loss) per common share
Basic		2,327,041																	2,730,131
Diluted		2,327,041																	12,704,269

	2017			Restatement Adjustments for the Six Months Ended June 30, 2017															2017
Quarterly Condensed Consolidated Statement of Operations	Six months ended June 30 as reported			Sales & Use Tax			Warrants			Debentures		Intangible Impairment		Deferred Revenue		Other Adjustments			Six months ended June 30 as restated
Revenues, net	$	15,568		$	-		$	-		$	-	$	-	$	198	$	(52	)	$	15,714

Cost of revenues		5,906																		5,906

Gross profit		9,662			-			-			-		-		198		(52	)		9,808

Operating expenses:
Engineering and product development		898																		898
Selling and marketing		5,821																		5,821
General and administrative		3,321			282												(52	)		3,551
		10,040			282			-			-		-		-		(52	)		10,270

Loss from operations		(378	)		(282	)		-			-		-		198		-			(462	)

Other (expense) income, net:
Interest expense, net		(2,921	)								854									(2,067	)
Change in fair value of warrant liability		(4	)					(10	)											(14	)
Change in fair value of embedded conversion feature											1,165									1,165
Loss on extinguishment of debentures		-																		-
Other income, net		6						-												6
		(2,919	)		-			(10	)		2,019		-		-		-			(910	)

Loss before income taxes		(3,297	)		(282	)		(10	)		2,019		-		198		-			(1,372	)
Income tax expense		(143	)																	(143	)
Net loss	$	(3,440	)	$	(282	)	$	(10	)	$	2,019	$	-	$	198		-			(1,515	)
Loss attributable to common shares	$	(3,440	)																$	(1,515	)

Loss per common share
Basic	$	(1.53	)																$	(0.67	)
Diluted	$	(1.53	)																$	(0.67	)
Shares used in computing loss per common share
Basic		2,252,301																		2,252,301
Diluted		2,252,301																		2,252,301

Quarterly Condensed Consolidated Balance Sheet	2017						Restatement Adjustments as of September 30, 2017														2017
	Balance as of September 30 as reported			Effect of restatement July 1			Sales & Use Tax			Warrants			Debentures			Intangible Impairment		Deferred Revenue			Balance as of September 30 as restated
Assets
Current assets:
Cash and cash equivalents	$	3,127		$	-		$	-		$	-		$	-		$	-	$	-		$	3,127
Accounts receivable, net		3,184																				3,184
Inventories		3,533																				3,533
Prepaid expenses and other current assets		209																				209
Total current assets		10,053															-					10,053


Property and equipment, net		8,658																				8,658
Intangible assets, net		12,302																				12,302
Goodwill		8,803																				8,803
Other assets		48																				48
Total assets	$	39,864		$	-		$	-		$	-		$	-		$	-	$	-		$	39,864


Liabilities and stockholders’ equity
Current liabilities:
Note payable	$	34		$	-		$	-		$	-		$	-		$	-	$	-		$	34
Current portion of long-term debt		1,936																				1,936
Accounts payable		1,907																				1,907
Other accrued liabilities		1,899			1,199			135														3,233
Deferred revenues		350			1,797														(195	)		1,952
Total current liabilities		6,126			2,996			135									-		(195	)		9,062

Long-term debt, net		8,842			-																	8,842
Senior secured convertible debentures, net		-			(7,799	)								7,799								-
Derivative liability senior secured convertible debentures		-			1,993									(1,993	)							-
Deferred tax liability		539			-																	539
Warrant liability		28			567						(340	)										255
Other liabilities		412																				412

Total liabilities		15,947			(2,243	)		135			(340	)		5,806			-		(195	)		19,110

Stockholders’ equity:
Preferred stock Series C Convertible Preferred Stock		4			-																	4
Common stock		3			-																	3
Additional paid-in capital		251,594			(27,814	)																223,780
Accumulated deficit		(227,686	)		30,057			(135	)		340			(5,806	)		-		195			(203,035	)
Accumulated other comprehensive income		2			-																	2
Total stockholders’ equity		23,917			2,243			(135	)		340			(5,806	)		-		195			20,754

Total liabilities and stockholders’ equity	$	39,864		$	-		$	-		$	-		$	-		$	-	$	-		$	39,864

	2017			Restatement Adjustments for Three Months Ended September 30, 2017															2017
Quarterly Condensed Consolidated Statement of Operations	Three months ended September 30 as reported			Sales & Use Tax			Warrants		Debentures			Intangible Impairment		Deferred Revenue		Other A djustments			Three months ended September 30 as restated
Revenues, net	$	7,285		$	-		$	-	$	-		$	-	$	195	$	(24	)	$	7,456

Cost of revenues		3,276																		3,276

Gross profit		4,009			-			-		-			-		195		(24	)		4,180

Operating expenses:
Engineering and product development		411																		411
Selling and marketing		2,492																		2,492
General and administrative		1,678			135												(24	)		1,789
		4,581			135			-		-			-		-		(24	)		4,692

Loss from operations		(572	)		(135	)									195					(512	)

Other (expense) income, net:
Interest expense, net		(1,343	)							562										(781	)
Change in fair value of warrant liability		81						340												421
Change in fair value of embedded conversion feature										1,993										1,993
Loss on extinguishment of debentures		(11,799	)							(8,361	)									(20,160	)
Other (expense) income, net		-																		-
		(13,061	)		-			340		(5,806	)		-		-		-			(18,527	)

Loss before income taxes		(13,633	)		(135	)		340		(5,806	)		-		195		-			(19,039	)
Income tax expense		(38	)																	(38	)
Net loss	$	(13,671	)	$	(135	)	$	340	$	(5,806	)	$	-	$	195	$	-		$	(19,077	)
Loss attributable to common shares	$	(8,235	)																$	(11,492	)
Loss attributable to Preferred Series C shares	$	(5,436	)																$	(7,585	)

Loss per common share
Basic	$	(3.32	)																$	(4.64	)
Diluted	$	(3.32	)																$	(4.64	)
Shares used in computing loss per common share
Basic		2,477,743																		2,477,743
Diluted		2,477,743																		2,477,743

Loss per Preferred Series C share - basic and diluted	$	(1,235.43	)																$	(1,723.84	)

Shares used in computing loss per basic and diluted Preferred Series C shares		4,400																		4,400

	2017			Restatement Adjustments for the Nine Months Ended September 30, 2017															2017
Quarterly Condensed Consolidated Statement of Operations	Nine months ended September 30 as reported			Sales & Use Tax			Warrants		Debentures			Intangible Impairment		Deferred Revenue		Other Adjustments			Nine months ended September 30 as restated
Revenues, net	$	22,852		$	-		$	-	$	-		$	-	$	393	$	(76	)	$	23,169

Cost of revenues		9,182																		9,182

Gross profit		13,670			-			-		-			-		393		(76	)		13,987

Operating expenses:
Engineering and product development		1,309																		1,309
Selling and marketing		8,312																		8,312
General and administrative		4,999			417			-									(76	)		5,340
		14,620			417			-		-			-		-		(76	)		14,961

Loss from operations		(950	)		(417	)		-		-			-		393		-			(974	)

Other (expense) income, net:
Interest expense, net		(4,264	)							1,416										(2,848	)
Change in fair value of warrant liability		77						330												407
Change in fair value of embedded conversion feature										3,158										3,158
Loss on extinguishment of debentures		(11,799	)							(8,361	)									(20,160	)
Other (expense) income, net		6						-		-										6
		(15,980	)		-			330		(3,787	)		-		-		-			(19,437	)

Loss before income taxes		(16,930	)		(417	)		330		(3,787	)		-		393		-			(20,411	)
Income tax expense		(181	)																	(181	)
Net loss	$	(17,111	)	$	(417	)	$	330	$	(3,787	)	$	-	$	393	$	-		$	(20,592	)
Loss attributable to common shares	$	(13,835	)																$	(16,650	)
Loss attributable to Preferred Series C shares	$	(3,276	)																$	(3,942	)

Loss per common share
Basic	$	(5.94	)																$	(7.15	)
Diluted	$	(5.94	)																$	(7.15	)
Shares used in computing loss per common share
Basic		2,328,274																		2,328,274
Diluted		2,328,274																		2,328,274

Loss per Preferred Series C share - basic and diluted	$	(2,208.96	)																$	(2,658.44	)

Shares used in computing loss per basic and diluted Preferred Series C shares		1,483																		1,483

Condensed Consolidated Statements of Cash Flows:	For the 2017, Three, Six and Nine Months Ended (as restated)
	March 31			June 30			September 30
Cash Flows From Operating Activities:
Net loss	$	(3,974	)	$	(1,515	)	$	(20,592	)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization		1,543			3,209			4,811
Provision for doubtful accounts		-			22			58
Gain on cancellation of distributor rights agreement		-			-			(40	)
Impairment of intangible assets		-			-			23
Stock-based compensation		52			73			136
Deferred taxes		60			120			180
Loss on extinguishment of debentures		-			-			20,160
Amortization of debt discount		247			765			927
Amortization of deferred financing costs		54			115			171
Change in fair value of warrant liability		671			14			(407	)
Change in fair value of embedded conversion feature		1,738			(1,165	)		(3,158	)
Changes in operating assets and liabilities:
Accounts receivable		102			(147	)		130
Inventories		147			(670	)		(716	)
Prepaid expenses and other assets		(188	)		243			406
Accounts payable		354			403			71
Other accrued liabilities		74			167			255
Other liabilities		36			84			108
Deferred revenues		(98	)		(20	)		(278	)
Net cash provided by operating activities		818			1,697			2,246

Cash Flows From Investing Activities:
Lasers placed-in-service		(683	)		(1,205	)		(1,451	)
Purchases of property and equipment		(200	)		(206	)		(320	)
Payments on distributor rights liability		-			(75	)		(115	)
Net cash used in investing activities		(883	)		(1,486	)		(1,886	)

Cash Flows From Financing Activities:
Repayments of long-term debt		-						(857	)
Payments on notes payable		(100	)		(201	)		(304	)
Net cash used in financing activities		(100	)		(201	)		(1,161	)

Net (decrease) increase in cash and cash equivalents		(165	)		10			(801	)
Cash and cash equivalents, beginning of period		3,928			3,928			3,928

Cash and cash equivalents, end of period	$	3,763		$	3,938		$	3,127

The impact from these changes for those above mentioned periods are below:

Quarterly Condensed Consolidated Balance Sheet	2018			Restatement Adjustments as of March 31, 2018															2018
	Balance as of March 31 as reported			Effect of restatement January 1			Sales & Use Tax			Warrants			Intangible Impairment			Deferred Revenue			Balance as of March 31 as restated
Assets
Current assets:
Cash and cash equivalents	$	3,417		$	-		$	-		$	-		$	-		$	-		$	3,417
Accounts receivable, net		2,491																		2,491
Inventories		3,029																		3,029
Prepaid expenses and other current assets		1,379																		1,379
Total current assets		10,316			-			-			-			-			-			10,316

Property and equipment, net		6,916																		6,916
Intangible assets, net		10,672			500									(50	)					11,122
Goodwill		8,803																		8,803
Other assets		48																		48
Total assets	$	36,755		$	500		$	-		$	-		$	(50	)	$	-		$	37,205


Liabilities and stockholders’ equity
Current liabilities:
Notes payable	$	252		$	-		$	-		$	-		$	-		$	-		$	252
Current portion of long-term debt		3,410																		3,410
Accounts payable		2,658																		2,658
Other accrued liabilities		2,216			1,221			104												3,541
Deferred revenues		440			1,580												(295	)		1,725
Total current liabilities		8,976			2,801			104			-			-			(295	)		11,586

Notes payable
Long-term debt, net		6,869																		6,869
Deferred tax liability		454																		454
Warrant liability		-			64						(40	)								234
Other liabilities		649																		647

Total liabilities		16,948			2,865			104			(40	)		-			(295	)		19,582

Stockholders’ equity:
Preferred stock - Series C Convertible Preferred stock		4																		4
Common stock		4																		4
Additional paid-in capital		251,662			(27,814	)														223,848
Accumulated deficit		(231,863	)		25,449			(104	)		40			(50	)		295			(206,233	)
Accumulated other comprehensive income		-																		-
Total stockholders’ equity		19,807			(2,365	)		(104	)		40			(50	)		295			17,623

Total liabilities and stockholders’ equity	$	36,755		$	500		$	-		$	-		$	(50	)	$	-		$	37,205

	2018				Restatement Adjustments as of March 31, 2018															2018
Quarterly Condensed Consolidated Statement of Operations	Three months ended March 31 as reported				Sales & Use Tax				Warrants			Intangible Impairment			Deferred Revenue		Other Adjustments			Three months ended March 31 as restated
Revenues, net	$	6,466		$	-			$	-		$	-			$	295	$	(23	)	$	6,738

Cost of revenues		3,295											50								3,345

Gross profit		3,171				-				-			(50	)		295		(23	)		3,393

Operating expenses:
Engineering and product development		338																			338
Selling and marketing		2,871																			2,871
General and administrative		1,803				104												(23	)		1,884
		5,012				104				-			-			-		(23	)		5,093

Loss from operations		(1,841	)			(104	)			-			(50	)		295		-			(1,700	)

Other (expenses) income, net:
Interest expense, net		(363	)																		(363	)
Change in fair value of warrant liability		-								40											40
Other (expense) income, net		21																			21
		(342	)			-				40			-			-		-			(302	)

Loss before income taxes		(2,183	)			(104	)			40			(50	)		295		-			(2,002	)
Income tax expense		(40	)																		(40	)
Net loss	$	(2,223	)		$	(104	)		$	40		$	(50	)	$	295	$	-		$	(2,042	)
Loss attributable to common shares	$	(547	)																	$	(504	)
Loss attributable to Preferred Series C shares	$	(1,676	)																	$	(1,537	)

Loss per common share
Basic	$	(0.13	)																	$	(0.12	)
Diluted	$	(0.13	)																	$	(0.12	)
Shares used in computing loss per common share
Basic		4,371,369																			4,371,369
Diluted		4,371,369																			4,371,369

Loss per Preferred Series C share - basic and diluted	$	(46.54	)																	$	(42.69	)

Shares used in computing loss per basic and diluted Preferred Series C shares		36,002																			36,002

Quarterly Condensed Consolidated Balance Sheet	2018			Restatement Adjustments as of June 30, 2018															2018
	Balance as of June 30 as reported			Effect of restatement April 1, ‘18			Sales & Use Tax			Warrants			Intangible Impairment			Deferred Revenue			Balance as of June 30 as restated
Assets
Current assets:
Cash and cash equivalents	$	14,445		$	-		$	-		$	-		$	-		$	-		$	14,445
Accounts receivable, net		2,574																		2,574
Inventories		2,413																		2,413
Prepaid expenses and other current assets		828																		828
Total current assets		20,260			-			-			-			-			-			20,260


Property and equipment, net		6,271																		6,271
Intangible assets, net		10,270			450									(50	)					10,670
Goodwill		8,803																		8,803
Other assets		48																		48
Total assets	$	45,652		$	450		$	-		$	-		$	(50	)	$	-		$	46,052


Liabilities and stockholders’ equity
Current liabilities:
Notes payable	$	51		$	-		$	-		$	-		$	-		$	-		$	51
Current portion of long-term debt		-																		-
Accounts payable		1,477																		1,477
Other accrued liabilities		2,330			1,325			99												3,754
Deferred revenues		393			1,285												124			1,802
Total current liabilities		4,251			2,610			99			-			-			124			7,084

Notes payable
Long-term debt, net		7,321																		7,321
Deferred tax liability		493																		493
Warrant liability		-			23						240									263
Other liabilities		287			1															288

Total liabilities		12,352			2,634			99			240			-			124			15,449

Stockholders’ equity:
Preferred Stock - Series C Convertible Preferred Stock		1																		1
Common stock		30																		30
Additional paid-in capital		266,487			(27,814	)														238,673
Accumulated deficit		(233,218	)		25,630			(99	)		(240	)		(50	)		(124	)		(208,101	)
Accumulated other Comprehensive income		-																		-
Total stockholders’ equity		33,300			(2,184	)		(99	)		(240	)		(50	)		(124	)		30,603

Total liabilities and stockholders’ equity	$	45,652		$	450		$	-		$	-		$	(50	)	$	-		$	46,052

	2018			Restatement Adjustments for the three months ended June 30, 2018															2018
Quarterly Condensed Consolidated Statement of Operations	Three months ended June 30 as reported			Sales & Use Tax			Warrants			Intangible Impairment			Deferred Revenue			Other Adjustments			Three months ended June 30 as restated
Revenues, net	$	7,533		$			$	-		$	-		$	(124	)	$	(21	)	$	7,388

Cost of revenues		3,499									50									3,549

Gross profit		4,034			-			-			(50	)		(124	)		(21	)		3,839

Operating expenses:
Engineering and product development		269																		269
Selling and marketing		2,378																		2,378
General and administrative		2,333			99												(21	)		2,411
		4,980			99			-			-			-			(21	)		5,058

Loss from operations		(946	)		(99	)		-			(50	)		(124	)		-			(1,219	)

Other (expense) income, net:
Interest expense, net		(328	)																	(328	)
Change in fair value of warrant liability		(23	)					(240	)											(263	)
Other expense, net		(18	)																	(18	)
		(369	)		-			(240	)		-			-			-			(609	)

Loss before income taxes		(1,315	)		(99	)		(240	)		(50	)		(124	)		-			(1,828	)
Income tax expense		(40	)																	(40	)
Net loss	$	(1,355	)	$	(99	)	$	(240	)	$	(50	)	$	(124	)	$	-		$	(1,868	)
Loss attributable to common shares	$	(797	)																$	(1,081	)
Loss attributable to Preferred Series C shares	$	(558	)																$	(787	)

Loss per common share
Basic	$	(0.06	)																$	(0.08	)
Diluted	$	(0.06	)																$	(0.08	)
Shares used in computing loss per common share
Basic		13,734,384																		13,734,384
Diluted		13,734,384																		13,724,384

Loss per Preferred Series C share - basic and diluted	$	(21.60	)																$	(30.49	)

Shares used in computing loss per basic and diluted Preferred Series C shares		25,847																		25,847

	2018			Restatement Adjustments for the Six Months Ended June 30, 2018														2018
Quarterly Condensed Consolidated Statement of Operations	Six months ended June 30 as reported			Sales & Use Tax			Warrants			Intangible Impairment			Deferred Revenue		Other Adjustments			Six months ended June 30 as restated
Revenues, net	$	13,999		$	-		$	-		$	-		$	171	$	(44	)	$	14,126

Cost of revenues		6,793			-			-			100			-		-			6,893

Gross profit		7,206			-			-			(100	)		171		(44	)		7,233

Operating expenses:
Engineering and product development		607			-			-			-			-		-			607
Selling and marketing		5,249			-			-			-			-		-			5,249
General and administrative		4,136			203			-			-			-		(44	)		4,295
		9,992			203			-			-			-		(44	)		10,151

Loss from operations		(2,786	)		(203	)		-			(100	)		171		-			(2,918	)

Other (expense) income , net:
Interest expense, net		(691	)		-			-			-			-		-			(691	)
Change in fair value of warrant liability		(22	)		-			(197	)		-			-					(219	)
Other (expense) income , net		1			-			-			-			-					1
		(712	)		-			(197	)		-			-		-			(909	)

Loss before income taxes		(3,498	)		(203	)		(197	)		(100	)		171		-			(3,827	)
Income tax expense		(80	)																(80	)
Net loss	$	(3,578	)	$	(203	)	$	(197	)	$	(100	)	$	171	$	-		$	(3,907	)
Loss attributable to common shares		(1,580	)															$	(1,724	)
Loss attributable to Preferred Series C shares		(1,998	)															$	(2,182	)

Loss per common share
Basic	$	(0.17	)															$	(0.19	)
Diluted	$	(0.17	)															$	(0.19	)
Shares used in computing loss per common share
Basic		9,078,741																	9,078,741
Diluted		9,078,741																	9,078,741

Loss per Preferred Series C share - basic and diluted	$	(64.69	)															$	(70.63	)

Shares used in computing loss per basic and diluted Preferred Series C shares		30,897																	30,897

Quarterly Condensed Consolidated Balance Sheet	2018						Restatement Adjustments as of September 30, 2018														2018
	Balance as of September 30 as reported			Effect of restatement July 1			Sales & Use Tax			Warrants			Debentures		Intangible Impairment			Deferred Revenue			Balance as of September 30 as restated
Assets
Current assets:
Cash and cash equivalents	$	15,888		$	-		$	-		$	-		$	-	$	-		$	-		$	15,888
Accounts Receivable, net		2,728																				2,728
Inventories		2,488																				2,488
Prepaid expenses and other current assets		670																				670
Total current assets		21,774			-			-			-			-		-			-			21,774


Property and Equipment, net		5,698																				5,698
intangible assets, net		9,867			400											(50	)					10,217
Goodwill		8,803																				8,803
Other assets		48																				48
Total assets	$	46,190		$	400		$	-		$	-		$	-	$	(50	)	$	-		$	46,540


Liabilities and stockholders’ equity
Current liabilities:
Accounts payable	$	1,663		$	-		$	-		$	-		$	-	$	-		$	-		$	1,663
Other accrued liabilities		2,697			1,424			128														4,247
Warrant liability		104			108						514											726
Deferred revenues		327			1,409														140			1,877
Total current liabilities		4,791			2,941			128			514								140			9,512

Long-term debt, net		7,362																				7,362
Deferred tax liability		392																				392
Warrant liability		-			155						460											615
Other liabilities		268			1																	269
Total liabilities		12,813			3,096			128			974					-			140			17,149

Stockholders’ equity
Preferred stock -Series C Convertible Preferred stock		1																				1
Common stock		30																				30
Additional paid-in capital		266,854			(27,814	)																239,040
Accumulated deficit		(233,508	)		25,117			(128	)		(974	)				(50	)		(140	)		(209,683	)
Total stockholders’ equity		33,377			(2,697	)		(128	)		(974	)				(50	)		(140	)		29,388

Total liabilities and stockholders’ equity	$	46,190		$	400		$	-		$	-		$	-	$	(50	)	$	-		$	46,540

	2018			Restatement Adjustments for the Three Months Ended September 30, 2018															2018
Quarterly Condensed Consolidated Statement of Operations	Three months ended September 30 as reported			Sales & Use Tax			Warrants			Intangible Impairment			Deferred Revenue			Other Adjustments			Three months ended September 30 as restated
Revenues, net	$	7,892		$	-		$	-		$	-		$	(140	)	$	(23	)	$	7,729

Cost of revenues		3,049									50									3,099

Gross profit		4,843			-			-			(50	)		(140	)		(23	)		4,630

Operating expenses:
Engineering and product development		224																		224
Selling and marketing		2,487																		2,487
General and administrative		2,184			128												(23	)		2,289
		4,895			128			-			-			-			(23	)		5,000

Loss from operations		(52	)		(128	)					(50	)		(140	)		-			(370	)

Other expense, net:
Interest expense, net		(239	)																	(239	)
Change in fair value of warrant liability		(79	)					(974	)											(1,053	)
Other expense, net		-																		-
		(318	)		-			(974	)		-			-			-			(1,292	)

Loss before income taxes		(370	)		(128	)		(974	)		(50	)		(140	)		-			(1,662	)
Income tax expense		80																		80
Net loss	$	(290	)	$	(128	)	$	(974	)	$	(50	)	$	(140	)	$	-		$	(1,582	)
Loss attributable to common shares	$	(257	)																$	(1,387	)
Loss attributable to Preferred Series C shares	$	(33	)																$	(195	)

Loss per common share
Basic	$	(0.01	)																$	(0.05	)
Diluted	$	(0.01	)																$	(0.05	)
Shares used in computing loss per common share
Basic		29,912,827																		29,912,827
Diluted		29,912,827																		29,812,827

Loss per Preferred Series C share - basic and diluted	$	(3.23	)																$	(19.38	)

Shares used in computing loss per basic and diluted Preferred Series C shares		10,049																		10,049

	2018			Restatement Adjustments for the Nine Months Ended September 30, 2018														2018
Quarterly Condensed Consolidated Statement of Operations	Nine months ended September 30 as reported			Sales & Use Tax			Warrants			Intangible Impairment			Deferred Revenue		Other Adjustments			Nine months ended September 30 as restated
Revenues, net	$	21,892		$	-		$	-		$	-		$	31	$	(67	)	$	21,856

Cost of revenues		9,842			-			-			150			-		-			9,992

Gross profit		12,050			-			-			(150	)		31		(67	)		11,864

Operating expenses:
Engineering and product development		831			-			-			-			-		-			831
Selling and marketing		7,737			-			-			-			-		-			7,737
General and administrative		6,319			331			-			-			-		(67	)		6,583
		14,887			331			-			-			-		(67	)		15,151

Loss from operations		(2,837	)		(331	)		-			(150	)		31		-			(3,287	)

Other expense, net:
Interest expense, net		(930	)		-			-			-			-		-			(930	)
Change in fair value of warranty liability		(101	)		-			(1,171	)		-			-					(1,272	)
Other income (expense), net		-			-			-			-			-					-
		(1,031	)		-			(1,171	)		-			-		-			(2,202	)

Loss before income taxes		(3,868	)		(331	)		(1,171	)		(150	)		30					(5,489	)
Income tax expense		-																	-
Net loss	$	(3,868	)	$	(331	)	$	(1,171	)	$	(150	)	$	31	$	-		$	(5,489	)
Loss attributable to common shares	$	(2,493	)															$	(3,539	)
Loss attributable to Preferred Series C shares	$	(1,375	)															$	(1,950	)

Loss per common share
Basic	$	(0.15	)															$	(0.22	)
Diluted	$	(0.15	)															$	(0.22	)
Shares used in computing loss per common share
Basic		16,099,752																	16,099,752
Diluted		16,099,752																	16,099,752

Loss per Preferred Series C share - basic and diluted	$	(57.58	)															$	(81.70	)

Shares used in computing loss per basic and diluted Preferred Series C shares		23,872																	23,872

Condensed Consolidated Statements of Cash Flows:	For the 2018, Three, Six and Nine Months Ended (as restated)
	March 31			June 30			September 30
Cash Flows From Operating Activities:
Net loss	$	(2,039	)	$	(3,907	)	$	(5,489	)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization		1,463			2,841			4,143
Provision for doubtful accounts		-			(49	)		53
• Loss (gain) on cancellation of distributor rights agreement		226			(11	)		(11	)
Stock-based compensation		19			203			570
Deferred taxes		40			80			(22	)
Loss on disposal of property and equipment and impairment of lasers placed in service		182			411			503
Amortization of debt discount		19			39			44
Amortization of deferred financing costs		21			42			79
Change in fair value of warrant liability		(41	)		197			1,272
Change in fair value of embedded conversion feature		-			-			-
Changes in operating assets and liabilities:
Accounts receivable		650			710			361
Inventories		(20	)		596			521
Prepaid expenses and other assets		(669	)		(296	)		(137	)
Accounts payable		381			(895	)		(614	)
Other accrued liabilities		(19	)		(3	)		754
Other liabilities		227			255			(3	)
Deferred revenues		(380	)		(303	)		(229	)
Net cash provided by (used in) operating activities		60			(68	)		1,795

Cash Flows From Investing Activities:
Lasers placed-in-service		(375	)		(885	)		(1,254	)
Purchases of property and equipment		(6	)		(6	)		(6	)
Payments on distributor rights liability		(24	)		(23	)		(23	)
Net cash used in investing activities		(405	)		(914	)		(1,283	)

Cash Flows From Financing Activities:
Proceeds from issuance of common stock		-			14,664			14,664
Offering costs		(202	)		-			-
Repayments of long-term debt		-			(3,000	)		(3,000	)
Payments on notes payable		(105	)		(306	)		(357	)
Net cash (used in) provided by financing activities		(307	)		11,358			11,307

Effect of exchange rate changes on cash		-			-			-
Net (decrease) increase in cash and cash equivalents		(652	)		10,376			11,819
Cash and cash equivalents, beginning of period		4,069			4,069			4,069

Cash and cash equivalents, end of period	$	3,417		$	14,445		$	15,888